Some researchers have reported that the TNF-α-mediated inhibition of the metabolic enzyme pyruvate dehydrogenase contributes to the pathogenesis of PAH, and elevated serum TNF-α levels are observed in patients with pulmonary hypertension secondary to chronic thromboembolic disease and connective tissue disease [40]. Here, TNF is linked to pulmonary hypertension.